Healthcare Contract Research Outsourcing Market To Reach Us$ 54.0 Bn By 2025

Global Healthcare Contract Research Outsourcing Market: Overview

Now-a-days the drug development process is characterized by large clinical trials, rapid changes in trials protocols for efficient management of data generated and complex procedures, with the growing price of in-house research, the demand for contract research outsourcing is also increasing. These trends have formed pressure on healthcare companies to develop efficient drug development and product commercialization process. Along with the drug development efficiency, healthcare companies are looking to merge and simplify the supply chain, directing sourcing among a preferred number of multiple service providers. In response, large CROs are actively expanding their offerings beyond core clinical research services. Contract research organizations work closely with healthcare companies to conduct clinical research programs and support marketing activities for them. An increasing number of healthcare companies are outsourcing their clinical trials and other services to the contract research organizations.

This report on the healthcare contract research outsourcing market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year.

Request For Sample @

Market related factors such as technological developments, product innovation, services offered, infrastructure facilities around the world, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the healthcare contract research outsourcing market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, product development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

Global Healthcare Contract Research Outsourcing Market: Key Segments

On the basis of services, the healthcare contract research outsourcing market is categorized into clinical trial services, regulatory services, clinical data management & biometrics, medical writing, pharmacovigilance, site management protocol and others. On the basis of therapeutic area the healthcare contract research outsourcing market is categorized into oncology/hematology, CNS, CV/metabolic, respiratory, infectious diseases, immunology, rare diseases, medical devices and others. In terms of end users, the healthcare contract research outsourcing market is segmented into hospitals, home care and clinics.

On the basis of geography, the healthcare contract research outsourcing market is segmented into North America, Europe, Asia Pacific and Rest of the world. North America comprises the U.S. and Canada. Europe comprises Germany, France, U.K., Spain, Italy and Rest of Europe. Asia-Pacific comprises China, India, Japan, Australia and New Zealand and Rest of Asia Pacific. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the healthcare contract research outsourcing market.

Request For Covid19 Impact Analysis Across Industries And Markets @

Companies Mentioned in Report

The report also profiles major players in the healthcare contract research outsourcing market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Syneos Health, PAREXEL International, ICON PLC, PRA Health Sciences, Inc., Charles River, Laboratory Corporation of America Holdings (Covance), IQVIA, Medpace, Pharmaceutical Product Development, LLC.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”


Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA – Canada Toll Free: 866-552-3453
Email: [email protected]